Skip to main content
. Author manuscript; available in PMC: 2020 Aug 4.
Published in final edited form as: Pharmacogenomics. 2015 Jun 17;16(8):877–90. doi: 10.2217/pgs.15.44

Figure 4. Kaplan–Meier survival estimates for RI, DCK and RRM1 expression.

Figure 4

(A) EFS comparison for patients with lowest quartile RI (RI < 3.21) versus the rest (RI > 3.21). (B) Bar graph showing the number of patients with low RI (RI < 3.21) and high RI (RI > 3.21) with or without induction death. (C & D) DFS comparison with respect to RRM1 (lowest quartile vs the rest) and DCK (based on median).DFS: Disease-free survival.